PMID: 32150704Mar 10, 2020Paper

Mechanism of action of cell therapy in hereditary diseases

Medicina
Marta Martinez-MorgaSalvador Martinez

Abstract

Inherited metabolism disorders are serious childhood diseases that lead to significant cognitive impairment and regression of psychomotor development. The pathophysiology of the neural progressive deterioration is usually associated with severe neuroinflammation and demyelination, and as a consequence, neurodegeneration. At the moment they have no adequate treatment and require early and aggressive therapeutic approaches, which entail high mortality rates and, very frequently, low degrees of functional improvement and survival. Bone marrow transplantation and bone marrow mesenchymal cells grafts are therapeutic and experimental therapies that improve the course of these diseases through different mechanisms of action: enzyme replacement, membrane exchange and regulation of the inflammatory process.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Deutsches medizinisches Journal
G SCHALTENBRAND
International Journal of Cardiology
Pradeep S RajendranKalyanam Shivkumar
Bulletin de la Société belge d'ophtalmologie
J J Martin
Bulletin Der Schweizerischen Akademie Der Medizinischen Wissenschaften
E Frauchiger
© 2021 Meta ULC. All rights reserved